MindMaze Therapeutics Holding SA (SWX:MMTX)

Market Cap	23.56M
Revenue (ttm)	1.20M
Net Income	-13.54M
EPS	-0.15
Shares Out	169.99M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,046,158
Open	0.1476
Previous Close	0.1458
Day's Range	0.1380 - 0.1476
52-Week Range	0.1380 - 2.9150
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About SWX:MMTX

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics’ ne...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 10
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: MMTX

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error